Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects

Tigecycline, a novel glycylcycline antibiotic, exhibits strong activity against gram-positive, gram-negative, aerobic, anaerobic, and atypical bacterial species, including many resistant pathogens, i.e., vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-res...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Muralidharan, Gopal, Micalizzi, Marlynne, Speth, John, Raible, Donald, Troy, Steven
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2005
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC538906/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15616299/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.49.1.220-229.2005
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia